3Balsamo A,Cicognani A,Baldzzi L, et al. CYP21 genotype, adult height, and pubertal development in 55 patients treatment for 21-hydroxylase deficiency [J]. J Clin Endocrinol Metab, 2003,88 (12) : 5680-5688.
4Green-Golan L,Yates C,Drinkard B, et al. Patients with classic congenital adrenal hyperplasia have decreased epinephrine reserve and defective glycemic control during prolonged moderate-intensity exrcise [J]. J Clin Endocrinol Metab, 2007,92 (8) : 3019-3024.
5Bonfig W, Bechtold S, Schmid H, et al. Reduced final height outcome in congenital adrenal hyperplasia under prednsone treatment: deceleration of growth velocity during puberty [J]. J Clin Endocrinol Metab,2007,92(5) :1635- 1639.
6Manoli I, Kcwaka-Gantenbein CH, Voutetakis A, et al. Early growth, pubertal development ,body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome [J]. Clin Endocrinol (Oxf), 2007,57 (5) : 669-676.
7Weintrob N,Dickerman Z,Sprecher E, et al. Non-clasical 21-hydroxylase deficiency in infancy and childhood: the effect of time of initiation of therapy on puberty and final height [J]. Eur J Endocrinol, 1997,136(2) : 188-195.
9Bachelot A, Chakthoura Z, Rouxel A, et al. Clasical forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in adults [J]. Horm Res,2008,69 (4):203- 211.
10Stikkelbkroeck NM, Hermus AR, Schouten D, et al. Prevalence of ovarian adrenal rest tumours and polyeystie ovaries in females with congenital adrenal hyperplasia :results of ultrasonography and MR inmaging [J]. Eur Radiol, 2004,14(10) : 1082-1086.
